ScienceDex / Researcher record
Hollands, Andrew Stephen
- Inhibrx, Inc. (no department on record)
From the FY2017 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2017
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2017): $1.4M in linked award amounts across 5 award records · Award-linked rank #4236.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2017 · selected5 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2017 award records by amount
NIH award records listing Hollands, Andrew Stephen as a PI. Multi-PI records show the full award amount for context.
- 6R44AI129161-03R44Contact PIDevelopment of multispecific antibodies for the treatment of Pseudomonas aeruginosa infection$936.9Kaward amount
- 1R44AI129161-01R44Contact PIDevelopment of multispecific antibodies for the treatment of Pseudomonas aeruginosa infection$223.9Kaward amount
- 6R43AI129162-02R43Contact PIDevelopment of Multispecific Antibodies for the treatment of Methicillin Resistant Staphylococcus aureus (MRSA) infection$116Kaward amount
- 1R43AI129162-01R43Contact PIDevelopment of Multispecific Antibodies for the treatment of Methicillin Resistant Staphylococcus aureus (MRSA) infection$108.4Kaward amount
- 4R44AI129161-02R44Contact PIDevelopment of multispecific antibodies for the treatment of Pseudomonas aeruginosa infection$63.4Kaward amount
Award organization
Organizations that administered FY2017 awards listing Hollands, Andrew Stephen as a PI.
FY2017 award administered by Inhibrx, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardInhibrx, Inc.
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #4236
- 2017Entered Top 25% NationallyRanked #4236